Free Brain Tumor Conference Spotlights Treatment, Support
CINCINNATIThe 2009 Midwest Regional Brain Tumor Conference, a free educational event for patients, caregivers and family members, will be held from 9 a.m. to 4:15 p.m. Saturday, June 20, at the
The conference, titled Hope, Innovation, Progress, Support, is presented by the Brain Tumor Center at the University of Cincinnati Neuroscience Institute, in partnership with the National Brain Tumor Society.
The conference will provide patients, survivors and caregivers with an opportunity to mingle with each other and to acquire information from brain tumor specialists and allied health professionals. The conference will offer formal presentations and informational displays. Topics will include the origins of brain tumors, advances in treatment, management of treatment side effects, long-term survivorship, rehabilitation, the patients bill of rights and financial resources.
Breakout sessions will focus on brain tumor types, including pituitary adenoma, acoustic neuroma, low-grade glioma, astrocytoma, glioblastoma and meningioma. Metastatic tumors also will be covered.
Featured speakers include:
- Ronald Warnick, MD, director of the Brain Tumor Center at the UC Neuroscience Institute.
- John Tew, MD, clinical director of the UC Neuroscience Institute
- Myles Pensak, MD, chair of the UC Department of Otolaryngology-Head and Neck Surgery.
- John Breneman, MD, professor of radiation oncology and neurosurgery at the UC Neuroscience Institute.
- Christopher McPherson, MD, director of surgical neuro-oncology at the Brain Tumor Center.
- Connie Menefee, caregiver.
The conference is directed by McPherson.
Fifteen-minute physician consults also will be available. Patients wishing a consult should contact Tara Orgon Stamper by June 10 at (513) 558-8649.
Although the symposium is free, participants are asked to register in advance by calling (513) 569-5354 or by sending an e-mail to eries@mayfieldclinic.com. Additional information, including a downloadable brochure and registration form, is available online at ucbraintumorcenter.com.
The
The UC Neuroscience Institute, a regional center of excellence at UC and University Hospital, is dedicated to patient care, research, education and the development of new treatments for stroke, brain and spinal tumors, epilepsy, traumatic brain and spinal injury, Parkinsons disease, Alzheimers disease, multiple sclerosis, disorders of the senses (swallowing, voice, hearing, pain, taste and smell) and psychiatric conditions (bipolar disorder, schizophrenia and depression).
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.